Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study
AUTOR(ES)
Masand, Prakash S.
FONTE
Physicians Postgraduate Press
RESUMO
Background: Irritable bowel syndrome (IBS) is a common disorder and is the largest diagnostic cohort seen by gastroenterologists. There is a bidirectional comorbidity of IBS and psychiatric illness. Ours is the first study to examine the effect of any selective serotonin reuptake inhibitor in subjects with IBS.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=314376Documentos Relacionados
- Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
- Intermittent theta-burst transcranial magnetic stimulation for autism spectrum disorder: an open-label pilot study
- A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
- Occupational therapy in spinocerebellar ataxia type 3: an open-label trial
- Occupational therapy in spinocerebellar ataxia type 3: an open-label trial
